Expected Pick For FDA Acting Chief Counsel Has CFSAN Experience

The anticipated selection of Michael Landa as FDA acting chief counsel indicates the Obama administration places a premium on food and device legal expertise in addition to substantive agency experience

More from Archive

More from Pink Sheet